CNA Financial’s Gossamer Bio GOSS Stock Holding History

CNA Financial’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-12,730	Closed	-$158K	–	195
2020 Q3	$158K	Buy	12,730 +570	+5%	+$7.56K	0.06%	182
2020 Q2	$158K	Buy	+12,160	New	+$153K	0.06%	174

Other funds holding GOSS

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

CNA Financial's GOSS Position: Q4 2020 in Review

CNA Financial sold out of Gossamer Bio (GOSS) in Q4 2020, closing a stake of 12,730 shares — an estimated $158K sold.

CNA Financial first reported a position in GOSS in Q2 2020 and held it in 2 quarters. The position peaked at $158K in Q3 2020. 122 funds tracked by Wall St. Rank hold GOSS as of Q4 2020.

CNA Financial reported no remaining Gossamer Bio position as of Q4 2020 after selling out during the quarter.
CNA Financial sold 12,730 Gossamer Bio shares in Q4 2020, an estimated $158K.
CNA Financial first reported a position in Gossamer Bio in Q2 2020 and held it in 2 quarters.
CNA Financial's Gossamer Bio position peaked at $158K in Q3 2020.
122 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2020.

Based on CNA Financial's 13F filing for Q4 2020, filed 12 Feb 2021.